Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04111458 |
Title | A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Boehringer Ingelheim |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | DEU |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Levine Cancer Institute | Charlotte | North Carolina | 28204 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Universitätsklinikum Frankfurt | Frankfurt am Main | 60590 | Germany | Details | ||
Universitätsklinikum Köln (AöR) | Köln | 50937 | Germany | Details | ||
Erasmus Medisch Centrum | Rotterdam | 3015 GD | Netherlands | Details | ||
Universitair Medisch Centrum Utrecht | Utrecht | 3584 CX | Netherlands | Details |